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Case report 
 
Delayed diagnosis of 22q11.2 deletion syndrome in an adult 
Chinese lady 
 
SHEA Yat-fung, LEE Chi-ho, Harinder Gill, CHOW Wing-sun, LAM Yui-ming, LUK Ho-ming, 
LAM Stephen Tak-sum and CHU Leung-wing 
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We report a 32 year-old Chinese lady with history of tetralogy of Fallot, presented to us with chest pain due to 
hypocalcemia secondary to hypoparathyroidism. With her dysmorphic facial features and intellectual disability 22q11.2 
deletion was suspected and confirmed by genetic study. Clinicians should consider the diagnosis of DiGeorge syndrome 
in adult patient with past medical history of congenital heart disease, facial dysmorphism, intellectual disability and 
primary hypoparathyroidism. 
Chin Med J 2012;125(16):2945-2947 
 
ypocalcemia due to hypoparathyroidism usually 
manifests with tetany including carpopedal spasm, 
circumoral or distal paresthesiae and in more severe 
depletion with seizures and confusion. Rarely 
hypocalcemia could present as chest pain.1,2 
Hypoparathyroidism in adult is most commonly due to 
acquired condition like autoimmune processes or injury 
of parathyroid glands due to surgery. Very rarely will an 
adult patient with hypoparathyroidism be due to genetic 
disorder, such as 22q11.2 deletion syndrome (22q11.2 
DS). 22q11.2 DS is the most common human deletion 
syndrome occurring in 1 in 4000 live births.3 The 
incidence is 1 in 10 989 in Chinese.4 It encompasses 
DiGeroge syndrome, velocardiofacial syndrome, 
cardiofacial syndrome and conotruncal anomaly face 
syndrome. More than 180 features have been associated 
with the deletion. Common clinical features include 
mental retardation, facial dysmorphism, cleft palate, 
velopharyngeal insufficiency with hypernasal speech, 
congenital heart diseases and hypocalcemia.3 We report a 
Chinese lady with underlying history of corrected 
tetralogy of Fallot (TOF) presented with chest pain and 
subsequently noted to have primary hypoparathyroidism 




A 32 year-old Chinese lady who was married and 
planning to have children was known to have TOF. She 
received transannular pericardial patch repair when she 
was three years old. She had residual left pulmonary 
artery hypoplasia and stenosis and received balloon 
angioplasty when she was 22 years old. Because of 
persistent right ventricular dysfunction, she received 
pulmonary valve replacement with tissue graft and repair 
of left pulmonary artery stenosis uneventfully one month 
before the current admission. Post-operatively, the 
ionized calcium was noted to be low varying between 
0.66–1.05 (normal range: 1.12–1.23) mmol/L, but this 
was overlooked previously. She was admitted into the 
General Medical Ward of Queen Mary Hospital, 
complaining of persistent retrosternal chest pain which 
was unrelated to exertion. She did not have any heart 
failure symptoms, carpopedal spasm or seizures. She had 
no history of recurrent infection or neck surgery. Her 
regular medications were warfarin and furosemide.  
 
On physical examination, the blood pressure was 98/57 
mm Hg, pulse 86 beats per minute, and oxygen saturation 
in room air was 99%. She was well oriented. She spoke 
with a hypernasal speech, and displayed dysmorphic 
facial features with mild hypertelorism, bulbous nasal tip, 
hooded eyelids, up-slanting narrow palpebral fissures, 
malar flatness and squared off ears (Figure 1 A and B). In 
the oral examination, we detected torus palatinus (Figure 
1C). In the cardiovascular examination, she had a central 
median sternotomy scar, and a right parasternal heave. 
The apex beat was located 1 cm lateral to the mid 
clavicular line and in the 5th intercostal space. A grade 
2/6 ejection systolic murmur was heard over the left 
upper sternal border. Respiratory, cardiovascular and 
neurological systems’ examination was normal. 
Chovostek’s and Trousseau’s sign were negative. 
Laboratory investigations showed hypocalcemia with an 
adjusted calcium level of 1.78 (normal range 2.11–2.55) 
mmol/L, and ionized calcium level of 0.88 (normal range 
1.12–1.23) mmol/L and hyperphosphatemia (1.73 mmol/L; 
H 
DOI: 10.3760/cma.j.issn.0366-6999.2012.16.027 
Department of Medicine, Queen Mary Hospital, the University of
Hong Kong, Hong Kong, China (Shea YF, Lee CH, Gill H, Chow
WS, Lam YM and Chu LW) 
Clinical Genetic Service, Department of Health,  The
Government of Hong Kong Special Administrative Region, Hong
Kong, China (Luk HM and Lam STS) 
Correspondence to: Dr. SHEA Yat-fung, Department of Medicine,
Queen Mary Hospital, the University of Hong Kong, 102 Pok Fu
Lam Road, Hong Kong (Tel: 852-94159313. Email:
elphashea@gmail.com) 
Chin Med J 2012;125(16):2945-2947 2946 
 
Figure 1. The patient’s face with dysmorphic features including mild hypertelorism, bulbous nasal tip, hooded eyelids, up-slanting narrow 
palpebral fissures, and malar flatness (1A), squared off ear (1B) and torus palatinus (1C). 
Figure 2. The FISH result. Vylsis LSI N25 locus probe was used in our analysis. Orange spots correspond to N25 locus which included the 
22q11.2 region and the green spot correspond to the 22q13.3 region, which was used as a control. In this metaphase study, normally, there 
should be four green and four orange spots over two sister chromatids for each of Chromosome 22. In our patient, four green spots but two 
orange spots were present only as one of the N25 locus has been deleted. 
 
normal range 0.88–1.45 mmol/L). She was confirmed to 
have primary hypoparathyroidism with a parathyroid 
hormone (PTH) level of 2.4 pmol/L (normal range 
1.1–7.3 pmol/L). The 24-hour urine calcium was 0.7 
mmol (normal range 2.0–7.4 mmol). Her 
electrocardiogram showed sinus rhythm with a right 
bundle branch block with a corrected QT interval of 512 
ms, and there were no ST-T changes. The serum creatine 
kinase and troponin I levels were normal. Her chest pain 
subsided after correction of the hypocalcemia. 
 
Reviewing her history, she had mild mental retardation 
and learning disabilities since childhood. She was noted 
to have thrombocytopenia varying between 72×109/L to 
98×109/L in the past seven years without any bleeding 
episodes. She was noted to have splenomegaly on 
ultrasound examination one year ago without any kidney 
abnormality. A flow cytometry study showed reduced 
T-cells with preserved CD4:CD8 ratio. The thyroid 
function test was normal. She had extraction of four teeth 
due to dental caries two years ago. She was prescribed 
with intravenous calcium gluconate and then placed on 
oral calcium carbonate (Oscal-500 2500 mg three times 
per day) and calcitriol (0.25 mg daily).  
 
In the view of her dysmorphic facial features, mental 
retardation, history of TOF, hypoparathyroidism, 
thrombocytopenia and splenomegaly, the 22q11.2 deletion 
syndrome was suspected. Clinical geneticist was consulted. 
Multiplex ligation dependent probe amplication (MLPA) 
study showed heterozygous deletion of 22q11.2 region, 
which subsequently confirmed by fluorescence in-situ 
hybridization (FISH) study (Figure 2). Her family was 
given genetic counseling related to this condition. The 
latest adjusted calcium level was 2.15 mmol/L nine months 
after the last admission and the patient did not have any 




Hypoparathyroidism in 22q11.2 DS is due to aplasia or 
hypoplasia of the parathyroid glands3 and occurred in 
65% of the patients with 22q11.2 DS.5 It is most 
commonly diagnosed soon after birth, as there is an 
abrupt interruption of transport of calcium from the 
mother to the fetus. The hypocalcemia generally 
improves over the next year as the parathyroid glands 
hypertrophy and an increase in dietary calcium intake 
occurs. Hypoparathyroidism has been described to be 
transient, persistent, late-onset or latent.3 The late onset or 
recurrence of hypocalcemia is often revealed during the 
time of metabolic stress such as cardiac surgery, illness, 
puberty or pregnancy.5 Our patient hypoparathyroidism 
can be described as late onset and may be precipitated by 
the cardiac repair surgery. Our patient is also unique as 
she presented only with chest pain without other features 
of hypocalcemia. The mechanism of hypocalcemia 
leading to angina chest pain has been proposed to be due 
to coronary artery spasm.2 Close monitoring of the 
patient’s calcium level can also help to prevent the 
development of seizures. 
 
As our patient has no symptoms suggestive of 
hypocalcemia all along, the diagnosis of 22q11.2 DS was 
not made previously. TOF is the most commonly 
associated cardiac anomaly in 22q11.2 DS with 
15%–20% of the patients affected by this cardiac defect. 
With the advancement of paediatric cardiology, 90% of 
the infants with TOF can live beyond 30 years of age.6 
Since cytogenetic testing for the condition is only 
available in 1994,7 a potential number of patients in adult 
congenital cardiac disease clinic may harbor the condition 
and not suspected by cardiologists. In one study involving 
103 patients in an adult congenital heart disease clinic, 
and using brief screening assessment including 
demographics, medical history, cognitive/ developmental 
history, behavioral and psychiatric history and limited 
physical examination, it was found that extracardiac 
features could predict 22q11.2 DS. The presence of two 
extra-cardiac features including facial dysmorphism and 
history of learning disabilities could be a good predictor 
of 22q11.2 DS with discriminant ability (DA) of over 
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80%, while a combination of any three features including 
facial dysmorphism, hypernasal speech, history of 
learning disabilities and age <30 years old yielded a DA 
of over 85% and a sensitivity of 100%. In fact, our patient 
has three of the extra-cardiac features! This case fully 
illustrates that careful observation of these extra-cardiac 
clinical features can help physicians, cardiologists as well 
as cardiothoracic surgeons to recognize and diagnose 
22q11.2 DS clinically,6 
 
In most patients, this condition is usually diagnosed 
shortly after birth.8 The condition often remains 
under-recognized in the adults as a result of its diverse 
clinical variability with multiple systems involvement, 
subtle clinical features, and lack of clinical genetics 
services and non-familiarity of clinicians to this 
condition.7 There are only a few studies on Chinese 
patients with 22q11.2 DS.9,10 Early diagnosis allows 
anticipatory clinical care. Most importantly the condition 
is autosomal dominant with 50% chance of having 
affected children.7 Because of poor cognitive function, 
22q11.2 DS patients are prone to dental problems because 
of poor dental hygiene, resulting in dental caries which 
may increase the risk of infective endocarditis.11 
 
The deletion happened in 22q11.2 region is because of its 
architecture with low copy number repeats (LCRs) with 
high homology contributing to the mispairing of LCR, 
unequal meiotic crossovers and aberrant 
inter-chromosomal exchanges.5,12 Most patients 
(70%–80%) have 3 Mb deletion encompassing 35–45 
genes while 15%–30% slightly smaller 1.5 Mb 
deletion.5,12 Over 90% of the deletions occur de novo 
without affected parents while 10% of patients will have 
deletion identified in the parents.12 Our patient has lost 
contact with her parents. The deletion results in abnormal 
development of facial structures, parathyroid gland, 
thyroid, thymus and the heart (especially the cardiac 
outflow tract and right ventricle). Deleted genes well 
characterized to be related to clinical phenotype include 
TBX which is important for cardiac, thymus & 
parathyroid development; catecho-O-methyltransferase 
(COMT) with behavioral & psychiatric problems and 
glycoprotein Ibβ with thrombocytopenia.12 
 
The typical deletion is submicroscopic that needs FISH 
for identification and the turnaround time is around 3 to 
14 days. Alternatively we can detect the microdeletion by 
polymerase chain reaction based technology like MLPA 
study which is faster or single nucleotide polymorphism 
(SNP) arrays for atypical microdeletion.3 All patients with 
the 22q11.2 deletion should refer to clinical geneticist for 
genetic counseling as the risk of recurrence for their 
offsprings will increase up to 50%. If the female patient is 
found to be pregnant, they should manage by high risk 
obstetric team. Detailed fetal echocardiography by 
experienced paediatric cardiologist is warranted as there 
is high chance of conotruncal anomalies among those 
22q11.2 deletion patients. Prenatal diagnosis of fetus by 
chorionic villous sampling as early as 11 weeks gestation 
and amniocentesis as early as 15 weeks of gestation is 
indicated. Fetus with pre-natal diagnosis of 22q11.2 
deletion syndrome with cardiac involvement should be 
delivered in tertiary center with neonatal intensive care 
unit and cardiothoracic surgery support. Prostaglandin E2 
infusion is needed for ductal dependent circulation or 
even cardiac surgery for critical left or right outflow tract 
obstructive lesions soon after birth. Calcium level should 
also need to be monitor closely during the neonatal 
period. Advice from immunologist may also indicated 
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